Phillips also named President of Altemia & Co., a Lobe Sciences CompanyVANCOUVER, British Columbia--(BUSINESS WIRE)--$LOBE #ShineTheLightOnSickleCell--Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a biopharmaceutical compan
New grant from the Bill & Melinda Gates Foundation supports the development of genetic therapies for infectious diseases. Aegis Life and Entos Pharmaceuticals will work collaboratively to utilize the Fusogenix PLV gene therapy delivery platform to
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addic
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is p
This year’s GreenTech, one of the world’s leading horticulture events, includes speaking sessions featuring Fluence experts and the launch of Fluence’s newest VYPR productAUSTIN, Texas & ROTTERDAM, Netherlands--(BUSINESS WIRE)--Fluence, a leading g
SASKATOON, Saskatchewan--(BUSINESS WIRE)--#agriculture--Ag-West Bio is pleased to announce that the 2018 to 2023 Diverse Field Crops Cluster (DFCC) Research Report is now available. Over the past five years, scientists across Canada have been working on 1
Vizgen Intends to Aggressively Defend Pioneering MERSCOPE Technology in Europe Just as it has in the U.S. Previous 10x Judgments Versus Competitors Have No Application to Vizgen CasesCAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc. (“Vizgen” or the
Findings from the ongoing Phase 1 MYTHIC study demonstrated a favorable and distinctive tolerability profile for monotherapy lunresertib Monotherapy antitumor activity observed, including confirmed partial response and several patients with long stable d
TORONTO--(BUSINESS WIRE)--Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada's leading on-demand virtual pharmacy, is excited to provide a comprehensive update on its business strategy and early growth in the virtual pharmacy sector. With a renewed focus on
Sol-Gel to receive up to $11 million in upfront payments and regulatory and sales milestones for both drugs, combined, plus additional royalties ranging from low double-digits to high-teens Non-dilutive capital strengthens Sol-Gel’s balance sheet Se
The Manitoba government is providing $500,000 to help Manitoba companies pursue new opportunities to export and diversify markets for their products, Economic Development, Investment and Trade Minister Jeff Wharton announced today.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.